Atea Pharmaceuticals, Inc. (AVIR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 290.94M |
| Enterprise Value | 196.07M |
| P/E Ratio | -2.18 |
| PEG Ratio | 0.09 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.56 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.61 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.63 |
| Return On Equity | -0.57 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -164.1M |
| Net Income | -158.35M |
| Diluted EPS | -1.94 |
| Total Cash | 256.01M |
| Total Cash/Share | 3.23 |
| Total Debt | 634,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 7.89 |
| Book Value Per Share | 2.95 |
| 52-Week Change | 28.06 |
| 52-Week High | 6.45 |
| 52-Week Low | 2.78 |
| Moving Average 50 Days | 4.82 |
| Moving Average 200 Days | 4.14 |
| Average Volume | 329,738 |
| Shares Outstanding | 80.03M |
| % Held by Institutions | 73.74 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |